$3.71
-0.17-4.26%
Last update: 12:07 PM
15 minutes delayed
Fate Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Fate Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.33 | $-0.47 | 29.8 % |
Mar 2024 | 2024-05-09 | $-0.47 | $-0.49 | 4.08 % |
Dec 2023 | 2024-02-26 | $-0.45 | $-0.52 | 13.5 % |
Sep 2023 | 2023-11-08 | $-0.46 | $-0.57 | 19.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $6.77M | $1.41M | 380.3 % |
Mar 2024 | 2024-05-09 | $1.93M | $1.11M | 73.4 % |
Dec 2023 | 2024-02-26 | $1.68M | $1.59M | 5.41 % |
Sep 2023 | 2023-11-08 | $1.94M | $890.00K | 118.4 % |
Fate Therapeutics (FATE) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.33, which beat the estimate of $-0.47.
The Actual Revenue was $6.8M, which beat the estimate of $1.4M.
Browse earnings estimates, EPS, and revenue on all stocks.